Synthetic endotoxin-binding peptide triggered TNF-α production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4804-4811

  Dankesreiter, Silke ^a   Hoess, Adolf ^b   Schneider Mergener, Jens ^c   Wagner, Hermann ^a   Miethke, Thomas ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MorphoSys AG   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; LIMULUS ANTI LIPOPOLYSACCHARIDE FACTOR; LIPID A; PEPTIDE; PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LIMULUS; MACROPHAGE; MOUSE; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0034193030     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4804     Document Type: Article

References (45)

1. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429.
2. Lamping, N., A. Hoess, B. Yu, T. C. Park, C. J. Kirschning, D. Pfeil, D. Reuter, S. D. Wright, F. Herrmann, and R. R. Schumann. 1996. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J. Immunol. 157:4648.
3. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison, 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
4. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang. A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284.
5. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.
6. Waage, A., and T. Espevik. 1988. Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J. Exp. Med. 167:1987.
7. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. 1989. The complex pattern of cytokines in serum from patients with meningococcal septic shock: association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169:333.
8. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cacheclin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869.
9. Galanos, C., M. A. Freudenberg, F. Jay, D. Nerkar, K. Veleva, H. Brade, and W. Strittmatter. 1984. Immunogenic properties of lipid A. Rev. Infect. Dis. 6:546.
10. Di Padova, F. E., H. Brade, G. R. Barclay, I. R. Poxton, E. Liehl, E. Schuetze, H. P. Kocher, G. Ramsay, M. H. Schreier, and D. B. McClelland. 1993. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect. Immun. 61:3863.
11. Nassif, X., J. C. Mathison, E. Wolfson, J. A. Koziol, R. J. Ulevitch, and M. So. 1992. Tumour necrosis factor a antibody protects against lethal meningococcaemia. Mol. Microbiol. 6:591.
12. Mathison, J. C., E. Wolfson, and R. J. Ulevitch. 1988. Participation of tumor necrosis factor in the mediation of Gram negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81:1925.
13. Echtenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762.
14. Elsbach, P. 1998. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J. Leukocyte Biol. 64:14.
15. Ooi, C. E., J. Weiss, M. E. Doerfler, and P. Elsbach. 1991. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J. Exp. Med. 174:649.
16. Marra, M. N., C. G. Wilde, J. E. Griffith, J. L. Snable, and R. W. Scott. 1990. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J. Immunol. 144:662.
17. Aketagawa, J., T. Miyata, S. Ohtsubo, T. Nakamura, T. Morita, H. Hayashida, S. Iwanaga, T. Takao, and Y, Shimonishi. 1986. Primary structure of Limulus anticoagulant anti-lipopolysaccharide factor. J. Biol. Chem. 261:7357.
18. Morita, T., S. Ohtsubo, T. Nakamura, S. Tanaka, S. Iwanaga, K. Ohashi, and M. Niwa. 1985. Isolation and biological activities of Limulus anticoagulant (anti-LPS factor) which interacts with lipopolysaccharide (LPS). J. Biochem. 97:1611.
19. Roth, R. I., D. Su, A. H. Child, N. R. Wainwright, and J. Levin. 1998. Limulus antilipopolysaccharide factor prevents modality late in the course of endotoxemia. J. Infect. Dis. 177:388.
20. Alpert, G., G. Baldwin, C. Thompson, N. Wainwright, T. J. Novitsky, Z. Gillis, J. Parsonnet, G. R. Fleisher, and G. R. Siber. 1992. Limulus antilipopolysaccharide factor protects rabbits from meningococcal endotoxin shock. J. Infect. Dis. 165:494.
21. Hoess, A., S. Watson, G. R. Siber, and R. Liddington. 1993. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. EMBO J. 12:3351.
22. Taylor, A. H., G. Heavner, M. Nedelman, D. Sherris, E. Brunt, D. Knight, and J. Ghrayeb. 1995. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J. Biol. Chem. 270:17934.
23. Little, R. G., D. N. Kelner, E. Lim, D. J. Burke, and P. J. Conlon. 1994. Functional domains of recombinant bactericidal/permeability increasing protein (rBP123). J. Biol. Chem. 269:1865.
24. Schumann, R. R., N. Lamping, and A. Hoess. 1997. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities. J. Immunol. 159:5599.
25. Rustici, A., M. Velucchi, R. Faggioni, M. Sironi, P. Ghezzi, S. Quataert, B Green, and M. Porro. 1993. Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. Science 259:361.
26. Kloczewiak, M., K. M. Black, P. Loiselle, J. M. Cavaillon, N. Wainwrighlt, and H. S. Warren 1994. Synthetic peptides that mimic the binding site of horseshoe crab antilipopolysaccharide factor. J. Infect. Dis. 170:1490.
27. Hoess, A., J. Schneider-Mergener, and R. C. Liddington. 1995. Identification of the LPS-binding domain of an endotoxin neutralising protein, Limulus anti-LPS factor. Prog. Clin. Biol. Res. 392:327.
28. Hirata, M., Y. Shimomura, M. Yoshida, S. C. Wright, and J. W. Larrick. 1994. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities. Prog. Clin. Biol. Res. 388:147.
29. Larrick, J. W., M. Hirata, H. Zheng, J. Zhong, D. Bolin, J. M. Cavaillon, H. S. Warren, and S. C. Wright. 1994. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J. Immunol. 152:231.
30. Tam, J. P., C. R. Wu, W. Liu, and J. W. Zhang. 1991. Disultide bond formation in peptides by dimethyl sulfoxide. J. Am. Chem. Soc. 113:6657.
31. Ried, C., C. Wahl, T. Miethke, G. Wellnhofer, C. Landgraf, J. Schneider-Mergener, and A. Hoess. 1996. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus antilipopolysaccharide factor. J. Biol. Chem. 271:28120.
32. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF: a primary mediator of the host response. Annu. Rev. Immunol. 7:625.
33. Lehmann, V., M. A. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165:657.
34. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175: 91.
35. Brandenburg, K., W. Richter, M. H. Koch, H. W. Meyer, and U. Seydel. 1998. Characterization of the nonlamellar cubic and HII structures of lipid A from Salmonella enterica serovar Minnesota by X-ray diffraction and freeze-fracture electron microscopy. Chem. Phys. Lipids 91:53.
36. Galanos, C., M. A. Freudenberg, and W. Reutter. 1979. Galactosamine-induced sensitization of the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76: 5939.
37. Decker, K., and D. Kappler. 1974. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol. 71:77.
38. Glauser, M. P,. G. Zanetti, J. D. Baumgartner, and J. Cohen. 1991. Septic shock: pathogenesis. Lancet 338:732.
39. Raetz, C. R. 1990. Biochemistry of endotoxins. Annu. Rev. Biochem. 59:129.
40. Rietschel, E. T., and H. Brade. 1992. Bacterial endotoxins. Sci. Am. 267:54.
41. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437.
42. Wright, S. D., P. S. Tobias, R. J. Ulevitch, and R. A. Ramos. 1989. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170:1231.
43. Ferrero, E., C. L. Hsieh, U. Francke, and S. M. Goyert. 1990. CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J. Immunol. 145:331.
44. Tobias, P. S., K. Soldau, J. A. Gegner, D. Mintz, and R. J. Ulevitch. 1995. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:10482.
45. Battafaraono, R. J., P. S. Dahlberg, C. A. Ratz, J. W. Johnston, B. H. Gray, J. R. Haseman, K. H. Mayo, and D. L. Dunn. 1995. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-indueed tumor necrosis factor-α secretion in vitro. Surgery 118:318.